#thyroideyedisease #TED #Amgen #Tepezza #Teprotumumab #Gravesophthalmopath #GravesEyeDisease #autoimmunedisorder #overactivethyroid #marketingauthorisation #MHRA #immunotherapy #insulinlikegrowthfactor1receptor #IGF1R #phase3OPTICtrial #OPTICtrial #proptosis
pharmatimes.com/news/amgens-...
1
0
0
0